Zürcher Nachrichten - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.248105
AFN 75.770596
ALL 92.762559
AMD 422.720519
ANG 2.0703
AOA 1061.880869
ARS 1706.354669
AUD 1.637736
AWG 2.083564
AZN 1.971037
BAM 1.955432
BBD 2.326962
BDT 141.823334
BGN 1.962242
BHD 0.435718
BIF 3453.950583
BMD 1.156733
BND 1.477822
BOB 13.465468
BRL 6.040925
BSD 1.155383
BTN 110.192281
BWP 15.565073
BYN 3.514139
BYR 22671.957183
BZD 2.323663
CAD 1.60514
CDF 2629.253412
CHF 0.941189
CLF 0.026851
CLP 1056.7913
CNY 7.800083
CNH 7.801606
COP 3603.822404
CRC 519.802266
CUC 1.156733
CUP 30.653411
CVE 110.244272
CZK 24.210763
DJF 205.741316
DKK 7.473191
DOP 67.627285
DZD 152.299364
EGP 57.668157
ERN 17.350988
ETB 186.897659
FJD 2.584377
FKP 0.854867
GBP 0.85516
GEL 3.019524
GGP 0.854867
GHS 12.651621
GIP 0.854867
GMD 85.024294
GNF 10149.091752
GTQ 8.815343
GYD 241.67456
HKD 9.077054
HNL 30.972177
HRK 7.532994
HTG 151.121586
HUF 363.017812
IDR 20622.34285
ILS 3.418265
IMP 0.854867
INR 110.410701
IQD 1513.515426
IRR 1590030.052589
ISK 142.166837
JEP 0.854867
JMD 182.965599
JOD 0.820169
JPY 184.272161
KES 149.331922
KGS 101.156702
KHR 4675.120976
KMF 493.925187
KPW 1041.059598
KRW 1638.639283
KWD 0.357061
KYD 0.962819
KZT 536.1092
LAK 26076.097131
LBP 103462.246866
LKR 384.457714
LRD 209.700572
LSL 18.691186
LTL 3.415531
LVL 0.699696
LYD 7.356617
MAD 10.715985
MDL 20.034233
MGA 4974.064769
MKD 61.513434
MMK 2428.897217
MNT 4159.622075
MOP 9.338444
MRU 46.399276
MUR 54.486429
MVR 17.871955
MWK 2003.423313
MXN 19.69164
MYR 4.726298
MZN 73.927211
NAD 18.691186
NGN 1572.659254
NIO 42.522005
NOK 10.922567
NPR 176.30785
NZD 1.940013
OMR 0.441007
PAB 1.155383
PEN 3.896867
PGK 5.190024
PHP 71.098608
PKR 320.900664
PLN 4.306226
PYG 6934.696128
QAR 4.211808
RON 5.236186
RSD 117.317942
RUB 97.161731
RWF 1698.980555
SAR 4.340955
SBD 9.310058
SCR 15.912008
SDG 694.622124
SEK 11.020235
SGD 1.480159
SHP 0.856984
SLE 28.344188
SLL 24256.10146
SOS 660.275854
SRD 43.926343
STD 23942.02751
STN 24.495394
SVC 10.109099
SYP 15039.835978
SZL 18.688486
THB 38.337629
TJS 10.669694
TMT 4.060131
TND 3.387463
TOP 2.785134
TRY 55.369898
TTD 7.827528
TWD 37.04043
TZS 3061.72433
UAH 51.684982
UGX 4292.192975
USD 1.156733
UYU 46.291296
UZS 13754.413873
VES 890.810236
VND 30246.82002
VUV 136.425482
WST 3.163074
XAF 655.833689
XAG 0.017878
XAU 0.000264
XCD 3.126128
XCG 2.082208
XDR 0.81787
XOF 655.833689
XPF 119.331742
YER 274.381102
ZAR 18.703474
ZMK 10411.984809
ZMW 21.835894
ZWL 372.467396
  • CMSC

    -0.0250

    21.45

    -0.12%

  • VOD

    0.2000

    16.42

    +1.22%

  • CMSD

    -0.0100

    21.58

    -0.05%

  • RBGPF

    0.0000

    71.34

    0%

  • RYCEF

    0.1300

    20.84

    +0.62%

  • RIO

    -0.4100

    95.68

    -0.43%

  • GSK

    -0.4785

    49.52

    -0.97%

  • BCE

    0.1500

    23.47

    +0.64%

  • NGG

    -0.1500

    81.05

    -0.19%

  • RELX

    -0.2400

    34.43

    -0.7%

  • JRI

    0.0635

    12.61

    +0.5%

  • BCC

    -0.8900

    83.24

    -1.07%

  • BTI

    -0.2900

    57.06

    -0.51%

  • AZN

    -0.7900

    156.45

    -0.5%

  • BP

    0.2196

    42.53

    +0.52%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

F.Schneider--NZN